These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21731184)

  • 1. Assessment of a bone biopsy technique for measuring tiludronate in horses: a preliminary study.
    Delguste C; Doucet M; Gabriel A; Guyonnet J; Lepage OM; Amory H
    Can J Vet Res; 2011 Apr; 75(2):128-33. PubMed ID: 21731184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial.
    Richbourg HA; Mitchell CF; Gillett AN; McNulty MA
    BMC Vet Res; 2018 Mar; 14(1):105. PubMed ID: 29554967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological effects of tiludronate in horses after long-term immobilization.
    Delguste C; Amory H; Doucet M; Piccot-Crézollet C; Thibaud D; Garnero P; Detilleux J; Lepage OM
    Bone; 2007 Sep; 41(3):414-21. PubMed ID: 17604709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of intravenous regional limb perfusion of tiludronate as an adjunctive treatment for lameness caused by navicular syndrome in horses.
    Schoonover MJ; Whitfield CT; Young JM; Sippel KM; Payton ME
    Am J Vet Res; 2018 Dec; 79(12):1313-1320. PubMed ID: 30457899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of two methods of tiludronate administration for the treatment of lameness caused by navicular syndrome in horses.
    Whitfield CT; Schoonover MJ; Holbrook TC; Payton ME; Sippel KM
    Am J Vet Res; 2016 Feb; 77(2):167-73. PubMed ID: 27027711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tiludronate in horses: A field population study.
    Popot MA; Jacobs M; Garcia P; Loup B; Guyonnet J; Toutain PL; Bailly-Chouriberry L; Bonnaire Y
    Equine Vet J; 2018 Jul; 50(4):488-492. PubMed ID: 29194746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiludronate infusion in the treatment of bone spavin: a double blind placebo-controlled trial.
    Gough MR; Thibaud D; Smith RK
    Equine Vet J; 2010 Jul; 42(5):381-7. PubMed ID: 20636772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of two intravenous administration regimens of tiludronate in healthy adult horses and effects on the bone resorption marker CTX-1.
    Delguste C; Amory H; Guyonnet J; Thibaud D; Garnero P; Detilleux J; Lepage OM; Doucet M
    J Vet Pharmacol Ther; 2008 Apr; 31(2):108-16. PubMed ID: 18307502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically relevant doses of tiludronate do not affect bone remodelling in pasture-exercised horses.
    Tippen SP; Metzger CE; Sacks SA; Allen MR; Mitchell CF; McNulty MA
    Equine Vet J; 2024 Jun; ():. PubMed ID: 38924597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration-dependent effects of tiludronate on equine articular cartilage explants incubated with and without interleukin-1β.
    Duesterdieck-Zellmer KF; Driscoll N; Ott JF
    Am J Vet Res; 2012 Oct; 73(10):1530-9. PubMed ID: 23013178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of tiludronate in the treatment of horses with signs of pain associated with osteoarthritic lesions of the thoracolumbar vertebral column.
    Coudry V; Thibaud D; Riccio B; Audigié F; Didierlaurent D; Denoix JM
    Am J Vet Res; 2007 Mar; 68(3):329-37. PubMed ID: 17331024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPLC/ESI-MS(n) method for non-amino bisphosphonates: application to the detection of tiludronate in equine plasma.
    Popot MA; Garcia P; Hubert C; Bolopion A; Bailly-Chouriberry L; Bonnaire Y; Thibaud D; Guyonnet J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 May; 958():108-16. PubMed ID: 24732148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Analysis of the Use of Tiludronate in Equine Practice: Safety on 1804 Horses, Efficacy on 343 Horses.
    Tischmacher A; Wilford S; Allen K; Mitchell RD; Parkin T; Denoix JM
    J Equine Vet Sci; 2022 Aug; 115():104007. PubMed ID: 35577109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and residence time of bisphosphonates in bone of horses.
    Knych HK; Janes J; Kennedy L; McKemie DS; Arthur RM; Samol MA; Uzal FA; Scollay M
    J Vet Diagn Invest; 2022 Jan; 34(1):23-27. PubMed ID: 34918585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone biopsy in the horse. 1. Method using the wing of ilium.
    Savage CJ; Jeffcott LB; Melsen F; Ostblom LC
    Zentralbl Veterinarmed A; 1991 Dec; 38(10):776-83. PubMed ID: 1796680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors that determine intensity of response to treatment with tiludronate in Paget's disease].
    Morales Piga A; Abraira Santos V; Rey Rey JS; de Abajo Iglesias F
    Med Clin (Barc); 1998 Feb; 110(7):254-8. PubMed ID: 9562949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of tuber coxae bone biopsy in the standing horse.
    Mitchell CF; Richbourg HA; Goupil BA; Gillett AN; McNulty MA
    Vet Surg; 2017 Apr; 46(3):396-402. PubMed ID: 28112812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and bioequivalence of two oral formulations of tiludronate in the treatment of Paget's disease of bone.
    Morales-Piga A; Del Pino J; Rapado A; Diaz-Curiel M; Pallares M; Gonzalez-Macias J
    Clin Ther; 1997; 19(5):963-74. PubMed ID: 9385484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy.
    Peris P; Alvarez L; Vidal S; Martínez MA; Monegal A; Guañabens N
    Clin Exp Rheumatol; 2007; 25(2):206-10. PubMed ID: 17543143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of tiludronate (Skelid) in animals.
    Davi H; Tronquet C; Caix J; Simiand J; Briot C; Berger Y; Thiercelin JF
    Xenobiotica; 1999 Oct; 29(10):1017-31. PubMed ID: 10574683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.